Cargando…
Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
Volumetric magnetic resonance imaging (vMRI) has been widely studied in Huntington's disease (HD) and is commonly used to assess treatment effects on brain atrophy in interventional trials. Global and regional trajectories of brain atrophy in HD, with early involvement of striatal regions, are...
Autores principales: | Kinnunen, Kirsi M., Mullin, Ariana P., Pustina, Dorian, Turner, Emily C., Burton, Jackson, Gordon, Mark F., Scahill, Rachael I., Gantman, Emily C., Noble, Simon, Romero, Klaus, Georgiou-Karistianis, Nellie, Schwarz, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569234/ https://www.ncbi.nlm.nih.gov/pubmed/34744964 http://dx.doi.org/10.3389/fneur.2021.712565 |
Ejemplares similares
-
Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
por: Kinnunen, Kirsi M., et al.
Publicado: (2021) -
A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021) -
Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015) -
Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation
por: Turner, Lauren M., et al.
Publicado: (2015) -
Robust Markers and Sample Sizes for Multicenter Trials of Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2020)